Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT07207564
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 100 Years
Healthy Volunteers
Accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

Key Dates

Start date
Aug 28, 2025
Status verified
Mar 2026
Primary completion
Jun 30, 2030
Completion
Jun 30, 2030

Study Design

Enrollment
4,500 participants (estimated)

Arms

  • Arm: Observational
    Participants complete a questionnaire, undergo collection of saliva or blood samples, and have their medical records reviewed on study.

Primary Outcome Measure

Pathologic features [ Time Frame: Baseline (collection of blood or saliva sample) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Laura Pacheco-Spann
[email protected]
904-953-0408
Clinical Trials Referral Office
[email protected]
855-776-0015
Mark E. Sherman, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in RochesterRochesterMinnesota55905
Laura Pacheco-Spann
[email protected]
904-953-0408
Clinical Trials Referral Office
[email protected]
855-776-0015
Celine M. Vachon, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Mayo Clinic in Florida· Jacksonville, FLMayo Clinic in Rochester· Rochester, MN

Related Studies